サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1398343

胃腸薬の世界市場：～2029年

Global Gastrointestinal Drugs Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 189 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
胃腸薬の世界市場：～2029年
出版日: 2023年12月22日
発行: QYResearch
ページ情報: 英文 189 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の胃腸薬の市場規模は、2023年の409億2,260万米ドルから、予測期間中は4.67%のCAGRで推移し、2029年には538億2,000万米ドルの規模に成長すると予測されています。

北米市場は2023年の125億7,500万米ドルから、4.35%のCAGRで推移し、2029年には162億3,800万米ドルに達すると予測されています。中国市場は2023年の59億8,800万米ドルから、6.36%のCAGRで推移し、2029年には86億7,000万米ドルに達すると予測されています。さらに、欧州市場は2023年の87億1,200万米ドルから、4.61％のCAGRで推移し、2029年には114億2,000万米ドルに達すると予測されています。

当レポートでは、世界の胃腸薬の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、タイプ・用途別の内訳、地域・主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査内容

  • 胃腸薬製品：イントロダクション
  • タイプ別市場
    • 成長率：2018 vs 2022 vs 2029
    • 処方薬
    • OTC薬
  • 用途別市場
    • 成長率：2018 vs 2022 vs 2029
    • 炎症性腸疾患
    • IBS疾患
    • 消化性潰瘍
    • 逆流性食道炎
  • 前提・制限
  • 調査目的
  • 調査年数

第2章 エグゼクティブサマリー

  • 世界の収益の推移・予測
  • 収益の推移・予測・シェア：地域別
  • 世界の販売数の推移・予測
  • 販売数の推移・予測・シェア：地域別
  • 北米
  • 欧州
  • 中国
  • アジア (中国を除く)
  • 中東・アフリカ・ラテンアメリカ

第3章 競合情勢：製造業者別

  • 販売数の推移・シェア・主要企業：製造業者別
  • 収益の推移・シェア・主要企業：製造業者別
  • 世界の主要企業：業界ランキング
  • 販売価格：製造業者別
  • 競合情勢の分析
  • 世界の主要製造業者：製造拠点の分布・本社
  • 世界の主要製造業者：設立日
  • M&A・拡張計画

第4章 市場規模：タイプ別

  • 販売数の推移・予測・市場シェア
  • 収益の推移・予測・市場シェア
  • 価格の推移・予測

第5章 市場規模：用途別

  • 販売数の推移・予測・市場シェア
  • 収益の推移・予測・市場シェア
  • 価格の推移・予測

第6章 北米

第7章 欧州

第8章 中国

第9章 アジア (中国を除く)

第10章 中東・アフリカ・ラテンアメリカ

第11章 企業概要

  • Takeda
  • AstraZeneca
  • Bayer
  • Pfizer
  • Sun Pharma
  • Teva
  • Zeria
  • Perrigo
  • Eisai Co.
  • Abbvie
  • Jiangzhong
  • AOSAIKANG Pharma
  • Luoxin Pharma
  • LIVZON
  • Huadong Pharmaceutical
  • Bausch Health

第12章 産業チェーン・販売チャネルの分析

  • 産業チェーン分析
  • 主要原材料
  • 製造モードとプロセス
  • 販売・マーケティング
  • 顧客

第13章 胃腸薬：市場力学

  • 産業動向
  • 市場促進要因
  • 市場課題
  • 市場抑制要因

第14章 世界の胃腸薬市場：主要調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 3. Global Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 4. Global Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million)
  • Table 5. Global Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million)
  • Table 6. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2023)
  • Table 7. Global Gastrointestinal Drugs Revenue Market Share by Region (2024-2029)
  • Table 8. Global Gastrointestinal Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (M Units)
  • Table 9. Global Gastrointestinal Drugs Sales by Region (2018-2023) & (M Units)
  • Table 10. Global Gastrointestinal Drugs Sales by Region (2024-2029) & (M Units)
  • Table 11. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2023)
  • Table 12. Global Gastrointestinal Drugs Sales Market Share by Region (2024-2029)
  • Table 13. Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023) & (M Units)
  • Table 14. Global Gastrointestinal Drugs Sales Share by Manufacturers (2018-2023)
  • Table 15. Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 16. Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023)
  • Table 17. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022
  • Table 18. Gastrointestinal Drugs Price by Manufacturers (2018-2023) & (USD/Unit)
  • Table 19. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2022)
  • Table 21. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters
  • Table 22. Global Key Manufacturers of Gastrointestinal Drugs, Founded Date
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
  • Table 25. Global Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
  • Table 26. Global Gastrointestinal Drugs Sales Share by Type (2018-2023)
  • Table 27. Global Gastrointestinal Drugs Sales Share by Type (2024-2029)
  • Table 28. Global Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 29. Global Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 30. Global Gastrointestinal Drugs Revenue Share by Type (2018-2023)
  • Table 31. Global Gastrointestinal Drugs Revenue Share by Type (2024-2029)
  • Table 32. Gastrointestinal Drugs Price by Type (2018-2023) & (USD/Unit)
  • Table 33. Global Gastrointestinal Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
  • Table 34. Global Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
  • Table 35. Global Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
  • Table 36. Global Gastrointestinal Drugs Sales Share by Application (2018-2023)
  • Table 37. Global Gastrointestinal Drugs Sales Share by Application (2024-2029)
  • Table 38. Global Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 39. Global Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 40. Global Gastrointestinal Drugs Revenue Share by Application (2018-2023)
  • Table 41. Global Gastrointestinal Drugs Revenue Share by Application (2024-2029)
  • Table 42. Gastrointestinal Drugs Price by Application (2018-2023) & (USD/Unit)
  • Table 43. Global Gastrointestinal Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
  • Table 44. North America Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
  • Table 45. North America Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
  • Table 46. North America Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 47. North America Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 48. North America Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
  • Table 49. North America Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
  • Table 50. North America Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 51. North America Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 52. North America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 53. North America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 54. North America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 55. North America Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units)
  • Table 56. North America Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units)
  • Table 57. Europe Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
  • Table 58. Europe Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
  • Table 59. Europe Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 60. Europe Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 61. Europe Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
  • Table 62. Europe Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
  • Table 63. Europe Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 64. Europe Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 65. Europe Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 66. Europe Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 67. Europe Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 68. Europe Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units)
  • Table 69. Europe Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units)
  • Table 70. China Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
  • Table 71. China Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
  • Table 72. China Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 73. China Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 74. China Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
  • Table 75. China Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
  • Table 76. China Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 77. China Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 78. Asia Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
  • Table 79. Asia Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
  • Table 80. Asia Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 81. Asia Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 82. Asia Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
  • Table 83. Asia Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
  • Table 84. Asia Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 85. Asia Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 86. Asia Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 87. Asia Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million)
  • Table 88. Asia Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million)
  • Table 89. Asia Gastrointestinal Drugs Sales by Region (2018-2023) & (M Units)
  • Table 90. Asia Gastrointestinal Drugs Sales by Region (2024-2029) & (M Units)
  • Table 91. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
  • Table 92. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
  • Table 93. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 94. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 95. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
  • Table 96. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
  • Table 97. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 99. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 100. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units)
  • Table 103. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units)
  • Table 104. Takeda Company Information
  • Table 105. Takeda Description and Major Businesses
  • Table 106. Takeda Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 107. Takeda Gastrointestinal Drugs Product Descriptions
  • Table 108. Takeda Recent Developments
  • Table 109. AstraZeneca Company Information
  • Table 110. AstraZeneca Description and Major Businesses
  • Table 111. AstraZeneca Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 112. AstraZeneca Gastrointestinal Drugs Product Descriptions
  • Table 113. AstraZeneca Recent Developments
  • Table 114. Bayer Company Information
  • Table 115. Bayer Description and Major Businesses
  • Table 116. Bayer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 117. Bayer Gastrointestinal Drugs Product Descriptions
  • Table 118. Bayer Recent Developments
  • Table 119. Pfizer Company Information
  • Table 120. Pfizer Description and Major Businesses
  • Table 121. Pfizer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 122. Pfizer Gastrointestinal Drugs Product Descriptions
  • Table 123. Pfizer Recent Developments
  • Table 124. Sun Pharma Company Information
  • Table 125. Sun Pharma Description and Major Businesses
  • Table 126. Sun Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 127. Sun Pharma Gastrointestinal Drugs Product Descriptions
  • Table 128. Teva Company Information
  • Table 129. Teva Description and Major Businesses
  • Table 130. Teva Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 131. Teva Gastrointestinal Drugs Product Descriptions
  • Table 132. Teva Recent Developments
  • Table 133. Zeria Company Information
  • Table 134. Zeria Description and Major Businesses
  • Table 135. Zeria Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 136. Zeria Gastrointestinal Drugs Product Descriptions
  • Table 137. Zeria Recent Developments
  • Table 138. Perrigo Company Information
  • Table 139. Perrigo Description and Major Businesses
  • Table 140. Perrigo Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 141. Perrigo Gastrointestinal Drugs Product Descriptions
  • Table 142. Eisai Co. Company Information
  • Table 143. Eisai Co. Description and Major Businesses
  • Table 144. Eisai Co. Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 145. Eisai Co. Gastrointestinal Drugs Product Descriptions
  • Table 146. Abbvie Company Information
  • Table 147. Abbvie Description and Major Businesses
  • Table 148. Abbvie Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 149. Abbvie Gastrointestinal Drugs Product Descriptions
  • Table 150. Abbvie Recent Developments
  • Table 151. Jiangzhong Company Information
  • Table 152. Jiangzhong Description and Major Businesses
  • Table 153. Jiangzhong Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 154. Jiangzhong Gastrointestinal Drugs Product Descriptions
  • Table 155. AOSAIKANG Pharma Company Information
  • Table 156. AOSAIKANG Pharma Description and Major Businesses
  • Table 157. AOSAIKANG Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 158. AOSAIKANG Pharma Gastrointestinal Drugs Product Descriptions
  • Table 159. Luoxin Pharma Company Information
  • Table 160. Luoxin Pharma Description and Major Businesses
  • Table 161. Luoxin Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 162. Luoxin Pharma Gastrointestinal Drugs Product Descriptions
  • Table 163. LIVZON Company Information
  • Table 164. LIVZON Description and Major Businesses
  • Table 165. LIVZON Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 166. LIVZON Gastrointestinal Drugs Product Descriptions
  • Table 167. Huadong Pharmaceutical Company Information
  • Table 168. Huadong Pharmaceutical Description and Major Businesses
  • Table 169. Huadong Pharmaceutical Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 170. Huadong Pharmaceutical Gastrointestinal Drugs Product Descriptions
  • Table 171. Bausch Health Company Information
  • Table 172. Bausch Health Description and Major Businesses
  • Table 173. Bausch Health Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
  • Table 174. Bausch Health Gastrointestinal Drugs Product Descriptions
  • Table 175. Bausch Health Recent Developments
  • Table 176. Key Raw Materials Lists
  • Table 177. Raw Materials Key Suppliers Lists
  • Table 178. Gastrointestinal Drugs Distributors List
  • Table 179. Gastrointestinal Drugs Customers List
  • Table 180. Gastrointestinal Drugs Market Trends
  • Table 181. Gastrointestinal Drugs Market Drivers
  • Table 182. Gastrointestinal Drugs Market Challenges
  • Table 183. Gastrointestinal Drugs Market Restraints
  • Table 184. Research Programs/Design for This Report
  • Table 185. Key Data Information from Secondary Sources
  • Table 186. Key Data Information from Primary Sources
  • Table 187. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Gastrointestinal Drugs Product Picture
  • Figure 2. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018-2029 (US$ Million)
  • Figure 3. Global Gastrointestinal Drugs Market Share by Type: 2022
  • Figure 4. Global Gastrointestinal Drugs Market Share by Type: 2029
  • Figure 5. Prescription Gastrointestinal Drug Product Picture
  • Figure 6. OTC Gastrointestinal Drug Product Picture
  • Figure 7. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 8. Global Gastrointestinal Drugs Market Share by Application: 2022
  • Figure 9. Global Gastrointestinal Drugs Market Share by Application: 2029
  • Figure 10. Inflammatory Bowel Disease
  • Figure 11. IBS Disease
  • Figure 12. Peptic Ulcer
  • Figure 13. GERD
  • Figure 14. Gastrointestinal Drugs Report Years Considered
  • Figure 15. Global Gastrointestinal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 16. Global Gastrointestinal Drugs Revenue 2018-2029 (US$ Million)
  • Figure 17. Global Gastrointestinal Drugs Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 18. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2022
  • Figure 19. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2029
  • Figure 20. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029)
  • Figure 21. Global Gastrointestinal Drugs Sales 2018-2029 (M Units)
  • Figure 22. Global Gastrointestinal Drugs Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (M Units)
  • Figure 23. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029)
  • Figure 24. North America Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
  • Figure 25. North America Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Europe Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
  • Figure 27. Europe Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. China Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
  • Figure 29. China Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 30. Asia (excluding China) Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
  • Figure 31. Asia (excluding China) Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 32. Middle East, Africa and Latin America Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
  • Figure 33. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 34. The Gastrointestinal Drugs Market Share of Top Largest Manufacturers Around the World in 2022
  • Figure 35. The Top Largest Manufacturers of Gastrointestinal Drugs in the World: Market Share by Gastrointestinal Drugs Revenue in 2022
  • Figure 36. Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
  • Figure 37. Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
  • Figure 38. Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
  • Figure 39. Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
  • Figure 40. North America Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
  • Figure 41. North America Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
  • Figure 42. North America Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
  • Figure 43. North America Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
  • Figure 44. North America Gastrointestinal Drugs Revenue Share by Country (2018-2029)
  • Figure 45. North America Gastrointestinal Drugs Sales Share by Country (2018-2029)
  • Figure 46. US Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 47. Canada Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 48. Europe Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
  • Figure 49. Europe Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
  • Figure 50. Europe Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
  • Figure 51. Europe Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
  • Figure 52. Europe Gastrointestinal Drugs Revenue Share by Country (2018-2029)
  • Figure 53. Europe Gastrointestinal Drugs Sales Share by Country (2018-2029)
  • Figure 54. Germany Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 55. France Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 56. UK Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 57. Italy Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 58. Russia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 59. China Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
  • Figure 60. China Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
  • Figure 61. China Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
  • Figure 62. China Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
  • Figure 63. Asia Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
  • Figure 64. Asia Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
  • Figure 65. Asia Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
  • Figure 66. Asia Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
  • Figure 67. Asia Gastrointestinal Drugs Revenue Share by Region (2018-2029)
  • Figure 68. Asia Gastrointestinal Drugs Sales Share by Region (2018-2029)
  • Figure 69. Japan Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 70. South Korea Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 71. Southeast Asia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 72. India Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 73. Australia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 74. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
  • Figure 75. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
  • Figure 76. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Share by Country (2018-2029)
  • Figure 77. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Share by Country (2018-2029)
  • Figure 78. Brazil Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 79. Mexico Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 80. Middle East Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 81. Africa Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 82. Gastrointestinal Drugs Value Chain
  • Figure 83. Gastrointestinal Drugs Production Process (Capsule)
  • Figure 84. Gastrointestinal Drugs Production Process (Injection)
  • Figure 85. Gastrointestinal Drugs Production Process (Tablet)
  • Figure 86. Channels of Distribution
  • Figure 87. Distributors Profiles
  • Figure 88. Bottom-up and Top-down Approaches for This Report
  • Figure 89. Data Triangulation
  • Figure 90. Key Executives Interviewed
目次

The global market for Gastrointestinal Drugs estimated at US$ 40922.6 million in the year 2023, is projected to reach a revised size of US$ 53820 million by 2029, growing at a CAGR of 4.67% during the forecast period 2023-2029.

The North America market for Gastrointestinal Drugs is estimated to increase from $ 12575 million in 2023 to reach $ 16238 million by 2029, at a CAGR of 4.35% during the forecast period of 2023 through 2029.

The China market for Gastrointestinal Drugs is estimated to increase from $ 5988 million in 2023 to reach $ 8670 million by 2029, at a CAGR of 6.36% during the forecast period of 2023 through 2029.

The Europe market for Gastrointestinal Drugs is estimated to increase from $ 8712 million in 2023 to reach $ 11420 million by 2029, at a CAGR of 4.61 % during the forecast period of 2023 through 2029.

The global key manufacturers of Gastrointestinal Drugs include: Takeda, Bausch Health, Abbvie, AstraZeneca, Teva, Bayer, Pfizer, Sun Pharma, etc. In 2022, the global top five players had a share approximately 40.67% in terms of revenue.

Report Includes:

This report presents an overview of global market for Gastrointestinal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Gastrointestinal Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Gastrointestinal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Gastrointestinal Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca, Sanofi, Bayer, Pfizer, GSK, Teva, Zeria, Perrigo, and Boehringer Ingelheim, etc.

By Company

  • Takeda
  • AstraZeneca
  • Bayer
  • Pfizer
  • Sun Pharma
  • Teva
  • Zeria
  • Perrigo
  • Eisai Co.
  • Abbvie
  • Jiangzhong
  • AOSAIKANG Pharma
  • Luoxin Pharma
  • LIVZON
  • Huadong Pharmaceutical
  • Bausch Health

Segment by Type

  • Prescription Gastrointestinal Drug
  • OTC Gastrointestinal Drug

Segment by Application

  • Inflammatory Bowel Disease
  • IBS Disease
  • Peptic Ulcer
  • GERD
  • Other

Segment by Region

  • North America
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Middle East
    • Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Gastrointestinal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

TABLE OF CONTENTS

1 STUDY COVERAGE

  • 1.1 Gastrointestinal Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Prescription Gastrointestinal Drug
    • 1.2.3 OTC Gastrointestinal Drug
  • 1.3 Market by Application
    • 1.3.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Inflammatory Bowel Disease
    • 1.3.3 IBS Disease
    • 1.3.4 Peptic Ulcer
    • 1.3.5 GERD
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Gastrointestinal Drugs Revenue Estimates and Forecasts 2018-2029
  • 2.2 Global Gastrointestinal Drugs Revenue by Region
    • 2.2.1 Global Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Gastrointestinal Drugs Revenue by Region (2018-2023)
    • 2.2.3 Global Gastrointestinal Drugs Revenue by Region (2024-2029)
    • 2.2.4 Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029)
  • 2.3 Global Gastrointestinal Drugs Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Gastrointestinal Drugs Sales by Region
    • 2.4.1 Global Gastrointestinal Drugs Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Gastrointestinal Drugs Sales by Region (2018-2023)
    • 2.4.3 Global Sales Gastrointestinal Drugs by Region (2024-2029)
    • 2.4.4 Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029)
  • 2.5 North America
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURERS

  • 3.1 Global Gastrointestinal Drugs Sales by Manufacturers
    • 3.1.1 Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top Largest Manufacturers of Gastrointestinal Drugs in 2022
  • 3.2 Global Gastrointestinal Drugs Revenue by Manufacturers
    • 3.2.1 Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top Companies by Gastrointestinal Drugs Revenue in 2022
  • 3.3 Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022
  • 3.4 Global Gastrointestinal Drugs Sales Price by Manufacturers (2018-2023)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Gastrointestinal Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Gastrointestinal Drugs, Founded Date
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Global Gastrointestinal Drugs Sales by Type
    • 4.1.1 Global Gastrointestinal Drugs Historical Sales by Type (2018-2023)
    • 4.1.2 Global Gastrointestinal Drugs Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
  • 4.2 Global Gastrointestinal Drugs Revenue by Type
    • 4.2.1 Global Gastrointestinal Drugs Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
  • 4.3 Global Gastrointestinal Drugs Price by Type
    • 4.3.1 Global Gastrointestinal Drugs Price by Type (2018-2023)
    • 4.3.2 Global Gastrointestinal Drugs Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

  • 5.1 Global Gastrointestinal Drugs Sales by Application
    • 5.1.1 Global Gastrointestinal Drugs Historical Sales by Application (2018-2023)
    • 5.1.2 Global Gastrointestinal Drugs Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
  • 5.2 Global Gastrointestinal Drugs Revenue by Application
    • 5.2.1 Global Gastrointestinal Drugs Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
  • 5.3 Global Gastrointestinal Drugs Price by Application
    • 5.3.1 Global Gastrointestinal Drugs Price by Application (2018-2023)
    • 5.3.2 Global Gastrointestinal Drugs Price Forecast by Application (2024-2029)

6 NORTH AMERICA

  • 6.1 North America Gastrointestinal Drugs Market Size by Type
    • 6.1.1 North America Gastrointestinal Drugs Sales by Type (2018-2029)
    • 6.1.2 North America Gastrointestinal Drugs Revenue by Type (2018-2029)
  • 6.2 North America Gastrointestinal Drugs Market Size by Application
    • 6.2.1 North America Gastrointestinal Drugs Sales by Application (2018-2029)
    • 6.2.2 North America Gastrointestinal Drugs Revenue by Application (2018-2029)
  • 6.3 North America Gastrointestinal Drugs Market Size by Country
    • 6.3.1 North America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 North America Gastrointestinal Drugs Revenue by Country (2018-2029)
    • 6.3.3 North America Gastrointestinal Drugs Sales by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 EUROPE

  • 7.1 Europe Gastrointestinal Drugs Market Size by Type
    • 7.1.1 Europe Gastrointestinal Drugs Sales by Type (2018-2029)
    • 7.1.2 Europe Gastrointestinal Drugs Revenue by Type (2018-2029)
  • 7.2 Europe Gastrointestinal Drugs Market Size by Application
    • 7.2.1 Europe Gastrointestinal Drugs Sales by Application (2018-2029)
    • 7.2.2 Europe Gastrointestinal Drugs Revenue by Application (2018-2029)
  • 7.3 Europe Gastrointestinal Drugs Market Size by Country
    • 7.3.1 Europe Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Gastrointestinal Drugs Revenue by Country (2018-2029)
    • 7.3.3 Europe Gastrointestinal Drugs Sales by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 UK
    • 7.3.7 Italy
    • 7.3.8 Russia

8 CHINA

  • 8.1 China Gastrointestinal Drugs Market Size by Type
    • 8.1.1 China Gastrointestinal Drugs Sales by Type (2018-2029)
    • 8.1.2 China Gastrointestinal Drugs Revenue by Type (2018-2029)
  • 8.2 China Gastrointestinal Drugs Market Size by Application
    • 8.2.1 China Gastrointestinal Drugs Sales by Application (2018-2029)
    • 8.2.2 China Gastrointestinal Drugs Revenue by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

  • 9.1 Asia Gastrointestinal Drugs Market Size by Type
    • 9.1.1 Asia Gastrointestinal Drugs Sales by Type (2018-2029)
    • 9.1.2 Asia Gastrointestinal Drugs Revenue by Type (2018-2029)
  • 9.2 Asia Gastrointestinal Drugs Market Size by Application
    • 9.2.1 Asia Gastrointestinal Drugs Sales by Application (2018-2029)
    • 9.2.2 Asia Gastrointestinal Drugs Revenue by Application (2018-2029)
  • 9.3 Asia Gastrointestinal Drugs Market Size by Region
    • 9.3.1 Asia Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Gastrointestinal Drugs Revenue by Region (2018-2029)
    • 9.3.3 Asia Gastrointestinal Drugs Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Southeast Asia
    • 9.3.7 India
    • 9.3.8 Australia

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

  • 10.1 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Country
    • 10.3.1 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Middle East
    • 10.3.7 Africa

11 CORPORATE PROFILE

  • 11.1 Takeda
    • 11.1.1 Takeda Company Information
    • 11.1.2 Takeda Overview
    • 11.1.3 Takeda Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Takeda Gastrointestinal Drugs Product Descriptions
    • 11.1.5 Takeda Recent Developments
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Company Information
    • 11.2.2 AstraZeneca Overview
    • 11.2.3 AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 AstraZeneca Gastrointestinal Drugs Product Descriptions
    • 11.2.5 AstraZeneca Recent Developments
  • 11.3 Bayer
    • 11.3.1 Bayer Company Information
    • 11.3.2 Bayer Overview
    • 11.3.3 Bayer Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Bayer Gastrointestinal Drugs Product Descriptions
    • 11.3.5 Bayer Recent Developments
  • 11.4 Pfizer
    • 11.4.1 Pfizer Company Information
    • 11.4.2 Pfizer Overview
    • 11.4.3 Pfizer Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Pfizer Gastrointestinal Drugs Product Descriptions
    • 11.4.5 Pfizer Recent Developments
  • 11.5 Sun Pharma
    • 11.5.1 Sun Pharma Company Information
    • 11.5.2 Sun Pharma Overview
    • 11.5.3 Sun Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Sun Pharma Gastrointestinal Drugs Product Descriptions
  • 11.6 Teva
    • 11.6.1 Teva Company Information
    • 11.6.2 Teva Overview
    • 11.6.3 Teva Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Teva Gastrointestinal Drugs Product Descriptions
    • 11.6.5 Teva Recent Developments
  • 11.7 Zeria
    • 11.7.1 Zeria Company Information
    • 11.7.2 Zeria Overview
    • 11.7.3 Zeria Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Zeria Gastrointestinal Drugs Product Descriptions
    • 11.7.5 Zeria Recent Developments
  • 11.8 Perrigo
    • 11.8.1 Perrigo Company Information
    • 11.8.2 Perrigo Overview
    • 11.8.3 Perrigo Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Perrigo Gastrointestinal Drugs Product Descriptions
  • 11.9 Eisai Co.
    • 11.9.1 Eisai Co. Company Information
    • 11.9.2 Eisai Co. Overview
    • 11.9.3 Eisai Co. Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 Eisai Co. Gastrointestinal Drugs Product Descriptions
  • 11.10 Abbvie
    • 11.10.1 Abbvie Company Information
    • 11.10.2 Abbvie Overview
    • 11.10.3 Abbvie Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Abbvie Gastrointestinal Drugs Product Descriptions
    • 11.10.5 Abbvie Recent Developments
  • 11.11 Jiangzhong
    • 11.11.1 Jiangzhong Company Information
    • 11.11.2 Jiangzhong Overview
    • 11.11.3 Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 Jiangzhong Gastrointestinal Drugs Product Descriptions
  • 11.12 AOSAIKANG Pharma
    • 11.12.1 AOSAIKANG Pharma Company Information
    • 11.12.2 AOSAIKANG Pharma Overview
    • 11.12.3 AOSAIKANG Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 AOSAIKANG Pharma Gastrointestinal Drugs Product Descriptions
  • 11.13 Luoxin Pharma
    • 11.13.1 Luoxin Pharma Company Information
    • 11.13.2 Luoxin Pharma Overview
    • 11.13.3 Luoxin Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.13.4 Luoxin Pharma Gastrointestinal Drugs Product Descriptions
  • 11.14 LIVZON
    • 11.14.1 LIVZON Company Information
    • 11.14.2 LIVZON Overview
    • 11.14.3 LIVZON Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.14.4 LIVZON Gastrointestinal Drugs Product Descriptions
  • 11.15 Huadong Pharmaceutical
    • 11.15.1 Huadong Pharmaceutical Company Information
    • 11.15.2 Huadong Pharmaceutical Overview
    • 11.15.3 Huadong Pharmaceutical Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.15.4 Huadong Pharmaceutical Gastrointestinal Drugs Product Descriptions
  • 11.16 Bausch Health
    • 11.16.1 Bausch Health Company Information
    • 11.16.2 Bausch Health Overview
    • 11.16.3 Bausch Health Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.16.4 Bausch Health Gastrointestinal Drugs Product Descriptions
    • 11.16.5 Bausch Health Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

  • 12.1 Gastrointestinal Drugs Industry Chain Analysis
  • 12.2 Gastrointestinal Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Gastrointestinal Drugs Production Mode & Process
  • 12.4 Gastrointestinal Drugs Sales and Marketing
    • 12.4.1 Gastrointestinal Drugs Sales Channels
    • 12.4.2 Gastrointestinal Drugs Distributors
  • 12.5 Gastrointestinal Drugs Customers

13 GASTROINTESTINAL DRUGS MARKET DYNAMICS

    • 13.1.1 Gastrointestinal Drugs Industry Trends
    • 13.1.2 Gastrointestinal Drugs Market Drivers
    • 13.1.3 Gastrointestinal Drugs Market Challenges
    • 13.1.4 Gastrointestinal Drugs Market Restraints

14 KEY FINDINGS IN THE GLOBAL GASTROINTESTINAL DRUGS STUDY

15 APPENDIX

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer